NovoSorb MTX

One layer.
More options.

NovoSorb® MTX is a flexible reconstructive scaffold supporting clinicians in the treatment of varying full-thickness defects. NovoSorb MTX is ideal where a non-degradable top-layer is less suitable or where the combined clinical benefits of a monolayer covered by a bilayer are preferred.

NovoSorb MTX is a monolayer dermal matrix built with
NovoSorb technology

Feature Product

Fully biodegradable foam structure for tissue infiltration, implantable in a single procedure.

2mm thick open cell structure serves as a matrix to aid in the reconstruction of soft tissue for skin grafting or secondary intention healing.

Highly porous synthetic scaffold designed to:

  • Support volumetric fill of an open wound1-4
  • Often allow management of infection without removal of product6-8
  • Combine clinical benefits of a monolayer covered by a bilayer5
  • Perform reliably within a single, cost-effective, application1
  • Support management of highly exudative wounds

Indications

  • Partial and full thickness wounds
  • Pressure ulcers, venous ulcers, diabetic ulcers, chronic, and vascular ulcers
  • Surgical wounds (donor sites/grafts, post-Moh’s surgery, post-laser surgery, podiatric,
    and wound dehiscence)
  • Trauma wounds (abrasions, lacerations, partial thickness burns, and skin tears)
  • Draining wounds

Phases of NovoSorb MTX Integration

Plus Minus
BTM Work
Apply NovoSorb MTX

Apply by cutting to shape and affixing to the wound with
the clinician’s choice of fixation

BTM Work
Assess Integration

Integration time and appearance may vary based on patient and wound factors. It takes between one to two weeks to adhere to the underlying bed.

BTM Work
Final Closure

Upon integration, wound closure may be achieved in a one- or two stage reconstruction. The matrix will remain in place and slowly break down over time as the wound continues to heal.

Instructions for Use
Want more information about NovoSorb MTX?

Get in touch with PolyNovo representative

For full device details, including indications, contraindications, warnings and precautions, refer to the Instructions for Use.

References

  1. Data on file: 2023 Literature Review, MKU-036 v3.0.
  2. Solanki et. al. Journal of Plastic, Reconstructive andAesthetic Surgery. 2020; 73(10):1845-3.
  3. Wagstaff et. al. Burns Open. 2019; 3(1):12-30.
  4. Damkat-Thomas et. al. Plastic and Reconstructive Surgery – Global Open. 2019; 7(4):e2110.
  5. Data on file. LMR Clinical Review.
  6. Greenwood et. al. Burn Care Res. 2012; 33:163-73.
  7. Jennings et. al. Australasian Journal of Plastic Surgery. 2021; 4(1):67–70.
  8. Greenwood et. al. Burns Open. 2018;2(1):17-34.